CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shanghai RAAS Blood Products Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shanghai RAAS Blood Products Co Ltd
No. 2009
Wangyuan Road, Fengxian District
Phone: +86 2122130888p:+86 2122130888 SHANGHAI, SHA  201401  China Ticker: 002252002252

Business Summary
Shanghai RAAS Blood Products Co., Ltd. is a China-based company principally engaged in the research and development, manufacture and distribution of blood products. The Company's main products include human albumin and human immunoglobulin for intravenous injection, human coagulation factors and others. The Company is also engaged in the distribution of Chinese medicine products and foods. The Company distributes its products within domestic market and to overseas markets.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Acting Chairman of the Board, General Manager JunXu 58 4/25/2023 4/1/2012
Vice Chairman of the Board TrongHoang 55 5/21/2020 5/21/2020
Finance Director LeqiChen 35 10/28/2021 10/28/2021
9 additional Officers and Directors records available in full report.

General Information
Number of Employees: 3,121 (As of 12/31/2022)
Outstanding Shares: 6,645,480,758 (As of 11/22/2023)
Shareholders: 132,958
Stock Exchange: SHE
Fax Number: +86 2137515869


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024